AMA Backs Structured Vaccine Review - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

  • By

  • Kathryn Wighton

  • February 11, 2026

  • 4 min

Share

  • 1

    The AMA and Vaccine Integrity Project launched an initiative to assess vaccine safety and effectiveness for the 2026-2027 season.

  • 2

    This initiative aims to create a formal process for evaluating scientific evidence supporting respiratory virus vaccinations.

  • 3

    The review process will include expert panels, systematic literature reviews, and public protocols for data transparency.

  • 4

    The AMA's involvement marks a shift towards prioritizing public health evidence in vaccine recommendations.

  • 5

    The initiative seeks to restore confidence in vaccines through continuous evaluation and credible evidence for clinicians.

Original Source(s)

AMA Backs Structured Vaccine Review

  • by Kathryn Wighton

  • February 11, 2026

Related Content

Case Report: Mitochondrial insufficiency underlies cholinergic failure in post-vaccination long COVID: a candidate treatment protocol

MMRV Use May Reveal Vaccine Access Gaps

The study identified the populations most likely to be affected by reduced access to MMRV.

CDC Updates Cyclosporiasis Surveillance

More than 5,100 additional reports require further analysis as federal and state partners investigate several outbreaks and work to identify their sources.